查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1886576

人工智慧診斷市場－全球產業規模、佔有率、趨勢、機會和預測，按組件、診斷類型、地區和競爭格局分類，2020-2030年預測

Artificial Intelligence Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Component, By Diagnosis Type, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年全球人工智慧診斷市場規模為21億美元，預計2030年將以7.02%的複合年成長率成長至31.6億美元。全球人工智慧診斷市場涵蓋人工智慧演算法和機器學習技術在分析各種醫療資料（包括影像、基因組序列和患者記錄）方面的應用，旨在提高疾病的檢測、診斷和預後能力。市場擴張的主要促進因素包括全球慢性病盛行率的不斷上升、對早期準確疾病識別的迫切需求以及醫療保健系統對提高診斷效率的必要性。

市場概覽
預測期 2026-2030
市場規模：2024年 21億美元
市場規模：2030年 31.6億美元
複合年成長率：2025-2030年 7.02%
成長最快的細分市場 腫瘤學
最大的市場 北美洲

主要市場促進因素

人工智慧技術的進步是全球人工智慧診斷市場成長的主要驅動力。機器學習演算法、深度學習模型和運算處理能力的持續創新，顯著提升了人工智慧系統解讀複雜醫療資料的能力，使其更加精準。

主要市場挑戰

複雜且不斷演變的監管框架對全球人工智慧診斷市場的成長構成重大阻礙。這種環境要求嚴格的驗證和廣泛的核准流程，這直接延長了產品開發週期，並大幅提高了新技術進入市場的成本。

主要市場趨勢

人工智慧與穿戴式裝置和持續監測技術的融合，顯著拓展了診斷能力，使其超越了傳統的臨床環境。這些人工智慧驅動的穿戴式裝置能夠持續採集生命徵象和生理資料，從而實現即時評估和早期異常檢測，進而進行主動健康管理。

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：顧客之聲

第5章：全球人工智慧診斷市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按組件（軟體、硬體、服務）
    • 依診斷類型（心臟科、腫瘤學、病理學、放射學、神經病學、其他）
    • 按地區
    • 按公司（2024 年）
  • 市場地圖

第6章：北美人工智慧診斷市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲人工智慧診斷市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區人工智慧診斷市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲人工智慧診斷市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲人工智慧診斷市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章：市場動態

  • 促進要素
  • 挑戰

第12章：市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章：全球人工智慧診斷市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商議價能力
  • 顧客的力量
  • 替代產品的威脅

第15章：競爭格局

  • Vuno Inc.
  • CHC Healthcare Group
  • AIDoc Medical Ltd.
  • Imbio
  • AliveCor, Inc.
  • Digital Diagnostics Inc.
  • Retina AI, Inc.
  • Canon Medical Systems Corp.
  • Healthy.io Ltd
  • Milliman, Inc.

第16章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 22230

The Global Artificial Intelligence Diagnostics Market, valued at USD 2.10 Billion in 2024, is projected to experience a CAGR of 7.02% to reach USD 3.16 Billion by 2030. The Global Artificial Intelligence Diagnostics Market encompasses the application of AI algorithms and machine learning techniques to analyze diverse medical data, including imaging, genomic sequences, and patient records, for enhanced disease detection, diagnosis, and prognosis. Market expansion is primarily supported by the increasing global prevalence of chronic diseases, the critical demand for early and accurate disease identification, and the necessity for improved diagnostic efficiency within healthcare systems.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 2.10 Billion
Market Size 2030USD 3.16 Billion
CAGR 2025-20307.02%
Fastest Growing SegmentOncology
Largest MarketNorth America

Key Market Drivers

Advancements in artificial intelligence technologies represent a primary catalyst for growth within the global artificial intelligence diagnostics market. Continuous innovation in machine learning algorithms, deep learning models, and computational processing power has significantly enhanced the capability of AI systems to interpret complex medical data with greater precision. For example, according to "Advancements in Artificial Intelligence for Medical Computer-Aided Diagnosis," June 2024, an optimized XGBoost model achieved 98.50% accuracy in enhancing diagnostic accuracy for heart disease, demonstrating the tangible improvements these technologies bring to diagnostic precision.

Key Market Challenges

The complex and continuously evolving regulatory frameworks governing AI-powered diagnostic solutions present a significant impediment to the growth of the Global Artificial Intelligence Diagnostics Market. This environment mandates rigorous validation and extensive approval processes, which directly prolong product development timelines and substantially elevate the costs associated with market entry for new technologies. Such demands necessitate considerable investment in regulatory compliance and specialized expertise, forming a critical barrier for manufacturers.

Key Market Trends

The integration of AI with wearable devices and continuous monitoring is significantly expanding diagnostic capabilities beyond traditional clinical environments. These AI-powered wearables continuously collect vital signs and physiological data, enabling real-time assessment and early anomaly detection for proactive health management. The growing acceptance of AI in clinical practice is evident as the American Medical Association reported physician usage of AI surged from 38% in 2023 to 66% in 2024, indicating increasing trust in these tools.

Key Market Players

  • Vuno Inc.
  • CHC Healthcare Group
  • AIDoc Medical Ltd.
  • Imbio
  • AliveCor, Inc.
  • Digital Diagnostics Inc.
  • Retina AI, Inc.
  • Canon Medical Systems Corp.
  • Healthy.io Ltd
  • Milliman, Inc.

Report Scope:

In this report, the Global Artificial Intelligence Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Artificial Intelligence Diagnostics Market, By Component:

  • Software
  • Hardware
  • Services

Artificial Intelligence Diagnostics Market, By Diagnosis Type:

  • Cardiology
  • Oncology
  • Pathology
  • Radiology
  • Neurology
  • Others

Artificial Intelligence Diagnostics Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Artificial Intelligence Diagnostics Market.

Available Customizations:

Global Artificial Intelligence Diagnostics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Artificial Intelligence Diagnostics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Component (Software, Hardware, Services)
    • 5.2.2. By Diagnosis Type (Cardiology, Oncology, Pathology, Radiology, Neurology, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Artificial Intelligence Diagnostics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Component
    • 6.2.2. By Diagnosis Type
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Artificial Intelligence Diagnostics Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Component
        • 6.3.1.2.2. By Diagnosis Type
    • 6.3.2. Canada Artificial Intelligence Diagnostics Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Component
        • 6.3.2.2.2. By Diagnosis Type
    • 6.3.3. Mexico Artificial Intelligence Diagnostics Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Component
        • 6.3.3.2.2. By Diagnosis Type

7. Europe Artificial Intelligence Diagnostics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Component
    • 7.2.2. By Diagnosis Type
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Artificial Intelligence Diagnostics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Component
        • 7.3.1.2.2. By Diagnosis Type
    • 7.3.2. France Artificial Intelligence Diagnostics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Component
        • 7.3.2.2.2. By Diagnosis Type
    • 7.3.3. United Kingdom Artificial Intelligence Diagnostics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Component
        • 7.3.3.2.2. By Diagnosis Type
    • 7.3.4. Italy Artificial Intelligence Diagnostics Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Component
        • 7.3.4.2.2. By Diagnosis Type
    • 7.3.5. Spain Artificial Intelligence Diagnostics Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Component
        • 7.3.5.2.2. By Diagnosis Type

8. Asia Pacific Artificial Intelligence Diagnostics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Component
    • 8.2.2. By Diagnosis Type
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Artificial Intelligence Diagnostics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Component
        • 8.3.1.2.2. By Diagnosis Type
    • 8.3.2. India Artificial Intelligence Diagnostics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Component
        • 8.3.2.2.2. By Diagnosis Type
    • 8.3.3. Japan Artificial Intelligence Diagnostics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Component
        • 8.3.3.2.2. By Diagnosis Type
    • 8.3.4. South Korea Artificial Intelligence Diagnostics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Component
        • 8.3.4.2.2. By Diagnosis Type
    • 8.3.5. Australia Artificial Intelligence Diagnostics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Component
        • 8.3.5.2.2. By Diagnosis Type

9. Middle East & Africa Artificial Intelligence Diagnostics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Component
    • 9.2.2. By Diagnosis Type
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Artificial Intelligence Diagnostics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Component
        • 9.3.1.2.2. By Diagnosis Type
    • 9.3.2. UAE Artificial Intelligence Diagnostics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Component
        • 9.3.2.2.2. By Diagnosis Type
    • 9.3.3. South Africa Artificial Intelligence Diagnostics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Component
        • 9.3.3.2.2. By Diagnosis Type

10. South America Artificial Intelligence Diagnostics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Component
    • 10.2.2. By Diagnosis Type
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Artificial Intelligence Diagnostics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Component
        • 10.3.1.2.2. By Diagnosis Type
    • 10.3.2. Colombia Artificial Intelligence Diagnostics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Component
        • 10.3.2.2.2. By Diagnosis Type
    • 10.3.3. Argentina Artificial Intelligence Diagnostics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Component
        • 10.3.3.2.2. By Diagnosis Type

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Artificial Intelligence Diagnostics Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Vuno Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. CHC Healthcare Group
  • 15.3. AIDoc Medical Ltd.
  • 15.4. Imbio
  • 15.5. AliveCor, Inc.
  • 15.6. Digital Diagnostics Inc.
  • 15.7. Retina AI, Inc.
  • 15.8. Canon Medical Systems Corp.
  • 15.9. Healthy.io Ltd
  • 15.10. Milliman, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer